findmyKOL

Yiming Luo

Basic profile

Columbia University Irving Medical Center

ORCIDNPI
RegionNew York, NY · NortheastSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding2025–2025Why? →

Yiming Luo is a Rheumatology/Immunology physician affiliated with Columbia University Irving Medical Center. OpenAlex indexes 50 publications with 1,473 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
50publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,473citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 2025–2025

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    41.6%
    Corticosteroid31.2%
    Prednisone100%
    Part D<11 patients
    Antidiarrheal microorganisms10.4%
    Folic Acid100%
    Part D<11 patients
  • Cancer & immunology

    36%
    Folate Analog Metabolic Inhibitor21.6%
    Methotrexate100%
    Part D<11 patients
    TNF inhibitor14.4%
    Humira(Cf) Pen100%
    Part D<11 patients
  • Musculoskeletal

    13.6%
    Nonsteroidal Anti-inflammatory Drug13.6%
    Diclofenac Sodium100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20252025 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”